Mumps in Poland in 2018.


Journal

Przeglad epidemiologiczny
ISSN: 0033-2100
Titre abrégé: Przegl Epidemiol
Pays: Poland
ID NLM: 0413725

Informations de publication

Date de publication:
2020
Historique:
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline in mumps incidence for over a decade which is a result of conducted vaccinations, mumps is still a common disease among the children. To assess epidemiological situation of mumps in Poland in 2018, including vaccination coverage in Polish population, in comparison to previous years. The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins "Infectious diseases and poisonings in Poland in 2018" and "Vaccinations in Poland in 2018". In total, there were 1 585 mumps cases registered in Poland in 2018. Incidence of mumps was 4.1 per 100,000 and it was lower in comparison with 2017. The highest incidence (6.6 per 100 000) was registered in Opolskie voivodeship and the lowest (2.6) - in Warmińsko-mazurskie voivodeship. The highest incidence rate was observed among children aged 5 years (39.2 per 100 000). Incidence in men (5.0 per 100 000) was higher than in women (3.4). In 2018, 28 people were hospitalized due to mumps. Vaccination coverage of children aged 3 years in Poland in 2018 was 92,9% and it was lower by 1.1% in comparison with year 2017. Systematic execution of mumps vaccination in accordance with the National Immunisation Programme resulted in a significant decrease in the number of registered cases. Due to the high vaccination coverage further decline in the number of cases is expected.

Identifiants

pubmed: 33570314
doi: 10.32394/pe.74.33
doi:

Substances chimiques

Mumps Vaccine 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-410

Informations de copyright

© National Institute of Public Health – National Institute of Hygiene.

Auteurs

Joanna Bogusz (J)

National Institute of Public Health - National Institute of Hygiene, Department of Epidemiology of Infectious Diseases and Surveillance.

Iwona Paradowska-Stankiewicz (I)

National Institute of Public Health - National Institute of Hygiene, Department of Epidemiology of Infectious Diseases and Surveillance.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH